Herbert, Estelle
Engel-Hills, Penelope
Hattingh, Coenraad
Fouche, Jean-Paul
Kidd, Martin
Lochner, Christine
Kotze, Maritha J.
van Rensburg, Susan J.
Funding for this research was provided by:
National Research Foundation (2011)
Winetech (N07/09/203)
National Health Laboratory Service (94139)
National Research Foundation Competitive Programme for Rated Researchers (CPR20110726000022168)
Article History
Received: 24 April 2017
Accepted: 18 December 2017
First Online: 2 February 2018
Compliance with ethical standards
:
: Professors SJ van Rensburg and MJ Kotze are listed as inventors on patent number 2010/00058. Prof Kotze is also a director and shareholder of Gknowmix (Pty) Ltd. that has developed a database tool for research translation under the auspices of the Innovation Centre of the South African Medical Research Council. Prof SJ van Rensburg applied the Gknowmix database tool and open innovation genetic testing service delivery model for development of the Demyelinating Diseases GeneScreenSuperscript removed. A treatment regimen was developed for application with this genomic solution (patent number 2012/07347). The remaining authors declared no conflict of interest. No writing assistance was utilised in the preparation of this manuscript.